p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index, and 1 are not checked yet; 7 of the 38 sources its claims cite were checked for support.
Abstract
Cellular senescence is a permanent state of cell cycle arrest that protects the organism from tumorigenesis and regulates tissue integrity upon damage and during tissue remodeling. However, accumulation of senescent cells in tissues during aging contributes to age‐related pathologies. A deeper understanding of the mechanisms regulating the viability of senescent cells is therefore required. Here, we show that the CDK inhibitor p21 (CDKN1A) maintains the viability of DNA damage‐induced senescent cells. Upon p21 knockdown, senescent cells acquired multiple DNA lesions that activated ataxia telangiectasia mutated (ATM) and nuclear factor (NF)‐κB kinase, leading to decreased cell survival. NF‐κB activation induced TNF‐α secretion and JNK activation to mediate death of senescent cells in a caspase‐ and JNK‐dependent manner. Notably, p21 knockout in mice eliminated liver senescent stellate cells and alleviated liver fibrosis and collagen production. These findings define a novel pathway that regulates senescent cell viability and fibrosis.
Verified 2026-10-05 · 1 reference not checked yet
Overview
CoChat Summary
TL;DR
p21 (CDKN1A) is required to maintain the viability of DNA damage-induced senescent cells, and its loss triggers ATM/NF-κB/TNF-α/JNK signaling and caspase-dependent death. In mice, p21 knockout reduces senescent cells in fibrotic liver and alleviates liver fibrosis.
Key findings
- p21 knockdown selectively killed DNA damage-induced senescent (DIS) cells: 30% death in IMR-90 DIS cells, 26% reduction in DIS MEFs, 54% reduction in DIS BJ cells, and 60% lower viability in p21−/− MEFs versus WT; H1299 cells showed 75% reduction after p21 shRNA and etoposide.
- p21 knockdown in DIS cells intensified the DNA damage response (increased p-ATM, p-CHK2, γH2AX, p53), resumed DNA synthesis (BrdU incorporation), caused fragmented chromosomes/micronucleation, and increased sub-G1; microarrays showed 1,595 unique genes changed versus 82 in growing cells, with TNF-α mRNA increased 30-fold.
- Death after p21 knockdown was caspase- and JNK-dependent: pan-caspase inhibitor QVD only partially rescued viability (17% increase), while combined QVD plus JNK inhibitor or JNK knockdown completely rescued; p65 knockdown blocked TNF-α production but did not rescue death.
- In CCl4-treated mice, p21−/− livers had significantly fewer senescent cells, detectable apoptotic cells, reduced Sirius Red fibrosis, and lower TGF-β, COL1A1, and α-SMA expression; p21 knockdown also reduced COL1A1 mRNA by 48% at 24 h before cell death.
Methods
- In vitro senescence models used human IMR-90 and BJ fibroblasts, mouse embryonic fibroblasts, and H1299 cells; DIS was induced with etoposide (20 μM for MEFs/H1299, 50 μM for BJ/IMR-90) for 48 h, and OIS with H-RasV12. p21, p53, pRb, p65, or JNK1 were knocked down by siRNA/shRNA; viability was measured with PrestoBlue, with QVD, z-VAD, or SP600125 treatments where indicated.
- Molecular analyses included Affymetrix PrimeView microarrays (3 replicates) with WikiPathways/IPA enrichment, RT–PCR, immunoblotting, immunofluorescence, comet assay, BrdU incorporation, cell cycle flow cytometry, and ImageStreamX γH2AX foci quantification.
- In vivo, WT and p21−/− 8-week-old female mice received CCl4 for 6 weeks (n = 10 per group); livers were analyzed by SA-β-gal, cleaved caspase-3, Sirius Red, and RT–PCR. Statistical significance used Student’s t-test with P < 0.05.
Limitations
- The paper states that direct regulation of JNK phosphorylation and caspases by p21 cannot be excluded, and that further research is required to define the mode of cell death after p21 knockdown (e.g., necrotic or autophagic versus apoptotic).
- The paper states that mice were assigned to experimental groups by genotype without randomization or blinding.
- Evident from the text: the in vitro work relies mainly on fibroblast lines and one cancer line, and the in vivo work is limited to CCl4-induced liver fibrosis in female mice, so generalizability to other senescent cell types, tissues, and aging models is not established; the paper also notes multiple possible mechanisms for fibrosis alleviation that were not fully distinguished.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
4 Valid · 0 Not valid · 21 Not checked · 85 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Senescent cell elimination can indeed increase the proliferative capacity of stem cells and hence support tissue regeneration”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Supportedcites Chang et al, 2016 matched to “Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice” (2016) source
The Abstract (Results/Discussion passages) states that ABT263-mediated clearance of senescent cells 'significantly improved the clonogenicity (Fig. 3c) and long-term engraftment ability of irradiated HSCs' and that in normally aged mice it 'improved the clonogenicity of isolated MuSCs', with the authors concluding that 'selective clearance of SCs by a pharmacological agent is beneficial in part through its rejuvenation of aged tissue stem cells'. The passage on mechanism ('clearance of senescent HSCs by ABT263 treatment can promote the expansion of normal HSC clones') directly supports increased stem-cell proliferative capacity, and restored long-term repopulation/multilineage engraftment supports the regenerative consequence, in mice (HSCs and MuSCs). (LLM, conf=0.85)
- Supportedcites Yosef et al, 2016 matched to “Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL” (2016) source
The Abstract states that 'Elimination of senescent cells from the epidermis leads to an increase in hair-follicle stem cell proliferation', and the Results (ABT-737 eliminates p53-induced senescent cells from skin) report increased Ki67+ and CD34+/CD49fhigh bulge stem cells that 'repopulate the stem cell compartment'. The Discussion extends this to regeneration: 'these findings suggest that the clearance of senescent cells can lead to tissue renewal and improved fitness', with relevance to other tissues (haematopoietic system, ref 42) noted. The claim's hedged modality ('can') matches the source; the only caveat is that the evidence is in mouse epidermis and the authors explicitly did not observe prominent hair regrowth within their time frame. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These cells use autophagy for their maintenance”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Partly supportedcites Young et al, 2009 matched to “Autophagy mediates the mitotic senescence transition” (2009) sourceExperimental — accuracy not yet measured
Our copy confirms that senescent cells run elevated autophagy (Results, LC3-II accumulation and increased long-lived-protein degradation in Ras/MEK senescent IMR90, BJ and embryonic fibroblasts, with intact autophagic flux) and that autophagy is functionally required for the senescence phenotype, including IL6/IL8 production (Results and Discussion, Fig. 4D-E). But the source frames this as mediating the ACQUISITION/ESTABLISHMENT of senescence — 'important for the rapid protein remodelling required to make the efficient transition from a proliferative to a senescent state' (Introduction) — and it explicitly tested the maintenance idea and found against it: 'knockdown of ATG5/7 in established ras senescent BJ cells failed to reverse the senescence arrest... autophagy contributes to, at least, the establishment of senescence arrest' (Results and Discussion, Fig. 4). So the part attributed to this source that it does not support is 'for their maintenance' (ongoing maintenance of the established senescent state); the supported part is autophagy's role in establishing/quality of the senescence phenotype. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“DDR also participates in controlling regulation of the expression of immune ligands on senescent cells that mediate their recognition and consequent elimination by NK cells”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Supportedcites Sagiv et al, 2016 matched to “NKG2D ligands mediate immunosurveillance of senescent cells” (2016) source
The Introduction states that senescent cells present the NKG2D ligands MICA and ULBP2, enabling NK-cell recognition and elimination, and that a DNA damage response regulates ligand expression. The Discussion likewise attributes ligand regulation partly to the DNA damage response and says NKG2D receptor–ligand interaction is necessary for efficient elimination. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Cellular stress induced by persistent DDR is a central mechanism that drives senescence in aging and age‐related diseases”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Supportedcites Campisi, 2013 matched to “Aging, Cellular Senescence, and Cancer” (2013) source
The 'Genomic Damage' subsection (CELLULAR SENESCENCE: CAUSES) states that senescence-efficacious lesions generate persistent DDR signaling, distinct from the transient DDR of mild damage, and 'Activation of Tumor Suppressors' states that persistent DDR signaling appears to initiate the senescence growth arrest, accompanied by stress-responsive p38MAPK/PKC signaling and increased ROS. The aging/age-disease linkage is carried by the Introduction (senescence links multiple aging pathologies, degenerative and hyperplastic) and by SENESCENT CELLS: CHARACTERISTICS, which reports persistent DNA damage foci in aging mouse and primate tissues, plus 'genomic damage—a common cause of cellular senescence' (Immune Clearance). The source hedges some of this ('may senesce primarily', 'appears to initiate') and notes DDR-independent routes (p38MAPK hyperactivation), but it does treat persistent DDR as the central initiating mechanism, matching the claim's scope. (LLM, conf=0.82)
- Not checked yetcites Munoz‐Espin & Serrano, 2014
- Not checked yetcites Ovadya & Krizhanovsky, 2014 matched to “Senescent cells: SASPected drivers of age-related pathologies” (2014) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, the signal intensity of 1,595 unique genes changed significantly in response to p21 knockdown in DIS cells compared to only 82 in growing cells (Fig 2C).”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > Molecular pathways activated after p21 knockdown in DIS cells
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
63 more claims
Create a free account to see all 110 claims and to verify the 31 references still open.
- Probably not a substantial claim. 23
- It may state two separate claims as one. 24
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence also is associated with upregulation of anti-apoptotic proteins of the BCL-2 family, particularly BCL-2, BCL-Xl, and BCL-W [14,15,143,144]”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [144]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“p21 upregulation has also been suggested as a mechanism that enables senescent cells to resist apoptosis, thereby facilitating their retention in tissues (Yosef et al, 2017).”
From Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues (2025) · cites this paper as Yosef et al, 2017
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, p16 might not be a specific or sensitive marker for cellular senescence since not all p16 highly expressing (p16high) cells are necessarily senescent [4] and some senescent cells do not express p16 [5,6].”
From The heterogeneity of cellular senescence: insights at the single-cell level (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“Upregulation of the cell cycle inhibitor p21 contributes to apoptosis resistance, for example, by inhibiting p53-mediated apoptosis after DNA damage [256,257] and by preventing the cleavage of the apoptosis effector caspase-3 and the activation of the JNK pathway (both required for apoptosis) [144].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > p21 knockout alleviates liver fibrosis
“JQuantification of Sirius Red staining presented in (H).”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > p21 knockout alleviates liver fibrosis
“ISirius Red staining of DIS cells after transduction with sip21 and siCtrl.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > p21 regulates the DNA damage response in senescent cells
“Each specimen was evaluated in triplicate. At least 50 cells were analyzed per replica”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Materials and Methods > Comet assay
“A minimum of 50 individual cells per sample were scored in duplicates.”
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603 · cited 1×
“Preprocessing was performed with the Robust Microarray Averaging algorithm (Irizarry et al , 2003).”
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“Elimination of senescent cells may therefore allow better recovery of tissues, consistent with the finding that senescent cell elimination via transgenic techniques improves aging-associated phenotypes (Baker et al , 2011, 2016).”
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 4×
“…secretory phenotype (SASP) (Coppe et al , 2008), which reinforces senescence arrest in an autocrine manner (Acosta et al , 2008, 2013; Kuilman et al , 2008; Wajapeyee et al , 2008) and mediates immune surveillance of the senescent cells (Sagiv & Krizhanovsky, 2013; Sagiv et al…”
InfluentialNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 2×
“Elimination of senescent cells may therefore allow better recovery of tissues, consistent with the finding that senescent cell elimination via transgenic techniques improves aging-associated phenotypes (Baker et al , 2011, 2016).”
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · cited 3×
“…in the organism promoting local inflammation that drives tissue aging, tissue destruction, and potentially also tumorigenesis and metastasis in a cell non-autonomous manner (Krtolica et al , 2001; Campisi, 2013; Munoz-Espin & Serrano, 2014; Ovadya & Krizhanovsky, 2014; Salama et al , 2014).”
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“…accompanied by the p53 (TP53) target p21 (CDKN1A), inhibits cyclin-dependent kinases (CDKs), thereby preventing phosphorylation of the retinoblastoma protein (pRb) and thus in turn suppressing the expression of proliferation-associated genes (Narita et al , 2003, 2006; Collado et al , 2007).”
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 1×
“…termed the senescence-associated secretory phenotype (SASP) (Coppe et al , 2008), which reinforces senescence arrest in an autocrine manner (Acosta et al , 2008, 2013; Kuilman et al , 2008; Wajapeyee et al , 2008) and mediates immune surveillance of the senescent cells (Sagiv &…”
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
“p21 protects senescent cells from death by restricting JNK and caspase signaling under persistent DNA damage [87].”
Role of p53 in the Regulation of Cellular Senescence
Mijit, M., Caracciolo, V., Melillo, A., Amicarelli, F., & Giordano, A. (2020) · Biomolecules · doi:10.3390/biom10030420 · Cited by 639
“p21cip1 knockout in senescent cells provokes programmed cell death through the caspase activation cascade [46].”
BackgroundMechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395
Senescence mechanisms and targets in the heart
Chen, M. S., Lee, R. T., & Garbern, J. C. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab161 · Cited by 327
Skin Aging, Cellular Senescence and Natural Polyphenols
Csekes, E., & Račková, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312641 · Cited by 320
The heterogeneity of cellular senescence: insights at the single-cell level
Cohn, R. L., Gasek, N. S., Kuchel, G. A., & Xu, M. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.04.011 · Cited by 294
Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Saleh, T., Bloukh, S., Carpenter, V. J., Alwohoush, E., Bakeer, J., Darwish, S., Azab, B., & Gewirtz, D. A. (2020) · Cancers · doi:10.3390/cancers12040822 · Cited by 290
Cellular senescence in development, regeneration and disease
Rhinn, M., Ritschka, B., & Keyes, W. M. (2019) · Development · doi:10.1242/dev.151837 · Cited by 279
“In the context of oncogene- or damageinduced senescence, by contrast, it is likely that there is little or no apoptosis, as p21 levels are maintained (Yosef et al., 2017), but senescent cells are cleared by the immune system within approximately two weeks (Kang et al.”
BackgroundNuclear genomic instability and aging
Niedernhofer, L. J., Gurkar, A. U., Wang, Y., Vijg, J., Hoeijmakers, J. H. J., & Robbins, P. D. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012239 · Cited by 275
Riegger, J., Schoppa, A., Ruths, L., Haffner-Luntzer, M., & Ignatius, A. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00489-y · Cited by 235
“Yosef et al. showed that p21 knockdown leads to a decreased cell survival of senescent cells, implying a shift from senescence towards apoptosis in the absence of p21 [202].”
BackgroundThe ECM path of senescence in aging: components and modifiers
Levi, N., Papismadov, N., Solomonov, I., Sagi, I., & Krizhanovsky, V. (2020) · The FEBS Journal · doi:10.1111/febs.15282 · Cited by 219
Self-citationInflammation and DNA damage: cause, effect or both
Pezone, A., Olivieri, F., Napoli, M. V., Procopio, A., Avvedimento, E. V., & Gabrielli, A. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00905-1 · Cited by 212
Cellular senescence: Molecular mechanisms and pathogenicity
Wei, W., & Ji, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26956 · Cited by 210
Strategies targeting cellular senescence
Ovadya, Y., & Krizhanovsky, V. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95149 · Cited by 200
“Recent studies highlight the p53/p21 axis as a promising target for development of novel senolytics (49, 60).”
BackgroundSelf-citationSenescent Cells: Emerging Targets for Human Aging and Age-Related Diseases
Song, S., Lam, E. W.-F., Tchkonia, T., Kirkland, J. L., & Sun, Y. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.03.008 · Cited by 195
Cellular senescence in cancer: from mechanisms to detection
Ou, H., Hoffmann, R., González‐López, C., Doherty, G. J., Korkola, J. E., & Muñoz‐Espín, D. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12807 · Cited by 190
Martins, S. G., Zilhão, R., Þorsteinsdóttir, S., & Carlos, A. R. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.673002 · Cited by 180
“Another indication of an effect of DNA damage on the expression of ECM components came from a study on the CDK inhibitor p21 (Yosef et al., 2017), a negative regulator of the cell cycle, which can be induced by p53 and drive cell cycle arrest (Williams and Schumacher, 2016).”
BackgroundRegulation of Survival Networks in Senescent Cells: From Mechanisms to Interventions
Soto-Gamez, A., Quax, W. J., & Demaria, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.05.036 · Cited by 175
“Importantly, these effects were not limited to normal fibroblasts but were also observed in a p53 mutated non-small cell lung cancer cell line (H1299) [54].”
BackgroundInfluentialRegulation of senescence traits by MAPKs
Anerillas, C., Abdelmohsen, K., & Gorospe, M. (2020) · GeroScience · doi:10.1007/s11357-020-00183-3 · Cited by 166
“To persist within tissues, senescent cells rely on pro-survival nodes, including proteins in the antiapoptotic programs driven by BCL2, PI3K-AKT, and p53 (Childs et al. 2014; Baar et al. 2017; Kirkland and Tchkonia 2017; Yosef et al. 2017).”
Cell Senescence, DNA Damage, and Metabolism
Shmulevich, R., & Krizhanovsky, V. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8043 · Cited by 157
Self-citationLee, K. S., Lin, S., Copland, D. A., Dick, A. D., & Liu, J. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02088-0 · Cited by 150
Elevated Local Senescence in Diabetic Wound Healing Is Linked to Pathological Repair via CXCR2
Wilkinson, H. N., Clowes, C., Banyard, K. L., Matteuci, P., Mace, K. A., & Hardman, M. J. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.01.005 · Cited by 135
p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells
Majewska, J., Agrawal, A., Mayo, A., Roitman, L., Chatterjee, R., Sekeresova Kralova, J., Landsberger, T., Katzenelenbogen, Y., Meir-Salame, T., Hagai, E., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01465-0 · Cited by 114
“Increased expression of p21 and BCL-XL is known to underlie senescent cells’ resistance to apoptosis and can contribute to their accumulation in tissues 9,10 .”
Self-citationYang, R., Chen, J., Zhang, J., Qin, R., Wang, R., Qiu, Y., Mao, Z., Goltzman, D., & Miao, D. (2020) · Aging Cell · doi:10.1111/acel.13095 · Cited by 133
“Additionally, p21, a target of p53, is also a senescent marker but appears to maintain the viability of senescent cells (Yosef et al., 2017).”
BackgroundLi, C., Xie, N., Li, Y., Liu, C., Hou, F. F., & Wang, J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.11.006 · Cited by 120
Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities
Song, S., Tchkonia, T., Jiang, J., Kirkland, J. L., & Sun, Y. (2020) · Advanced Science · doi:10.1002/advs.202002611 · Cited by 129
Huang, Z., Gan, S., Zhuang, X., Chen, Y., Lu, L., Wang, Y., Qi, X., Feng, Q., Huang, Q., Du, B., et al. (2022) · Cells · doi:10.3390/cells11162472 · Cited by 129
Cellular senescence: a promising strategy for cancer therapy
Lee, S., & Lee, J.-S. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.1.294 · Cited by 115
Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents
Bojko, A., Czarnecka-Herok, J., Charzynska, A., Dabrowski, M., & Sikora, E. (2019) · Cells · doi:10.3390/cells8121501 · Cited by 108
“One of them, proposed by Krizhanonvsky, is noncanonical function of p21, namely, maintaining the viability of DNA-damaged cells by inhibition of the JNK pathway and caspase 3 [39].”
BackgroundMolecular pathways of senescence regulate placental structure and function
Gal, H., Lysenko, M., Stroganov, S., Vadai, E., Youssef, S. A., Tzadikevitch‐Geffen, K., Rotkopf, R., Biron‐Shental, T., de Bruin, A., Neeman, M., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100849 · Cited by 99
“Genotyping protocols for all genotypes have been previously described (Krizhanovsky et al , 2008; Yosef et al , 2017).”
Self-citationSenescence of alveolar epithelial progenitor cells: a critical driver of lung fibrosis
Parimon, T., Chen, P., Stripp, B. R., Liang, J., Jiang, D., Noble, P. W., Parks, W. C., & Yao, C. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00239.2023 · Cited by 110
Cellular senescence of renal tubular epithelial cells in acute kidney injury
Chen, J., Zhang, H., Yi, X., Dou, Q., Yang, X., He, Y., Chen, J., & Chen, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01831-9 · Cited by 110
“Furthermore, p21 can inhibit apoptosis in senescent cells by suppressing the JNK and caspase signaling pathways [25].”
BackgroundLoss of IGFBP2 mediates alveolar type 2 cell senescence and promotes lung fibrosis
Chin, C., Ravichandran, R., Sanborn, K., Fleming, T. P., Wheatcroft, S. B., Kearney, M. T., Tokman, S., Walia, R., Smith, M. A., Flint, D. J., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100945 · Cited by 106
“9 Mounting evidence suggests that P21 and phosphorylation of H2AX are two key molecular markers in the senescence pathway 10–12 and that accumulation of P21 is typically observed during the process of senescence development.”
Evidence and perspectives of cell senescence in neurodegenerative diseases
Si, Z., Sun, L., & Wang, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111327 · Cited by 105
Dissecting primary and secondary senescence to enable new senotherapeutic strategies
Admasu, T. D., Rae, M. J., & Stolzing, A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101412 · Cited by 103
The role of mitochondria dysfunction and hepatic senescence in NAFLD development and progression
Dabravolski, S. A., Bezsonov, E. E., & Orekhov, A. N. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112041 · Cited by 82
Veitch, S., Njock, M., Chandy, M., Siraj, M. A., Chi, L., Mak, H., Yu, K., Rathnakumar, K., Perez-Romero, C. A., Chen, Z., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01458-z · Cited by 85
Liu, Y., Lomeli, I., & Kron, S. J. (2024) · Cells · doi:10.3390/cells13151281 · Cited by 77
“Additionally, p21 CIP may inhibit NF-κ B and subsequent JNK-cascade-dependent cell death in SnCs [127].”
BackgroundWillis, C. M., Nicaise, A. M., Bongarzone, E. R., Givogri, M., Reiter, C. R., Heintz, O., Jellison, E. R., Sutter, P. A., TeHennepe, G., Ananda, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57663-x · Cited by 76
Khalil, R., Diab‐Assaf, M., & Lemaître, J.-M. (2023) · Cells · doi:10.3390/cells12060915 · Cited by 74
Senescence in chronic wounds and potential targeted therapies
Wei, X., Li, M., Zheng, Z., Ma, J., Gao, Y., Chen, L., Peng, Y., Yu, S., & Yang, L. (2022) · Burns & Trauma · doi:10.1093/burnst/tkab045 · Cited by 73
Early SRC activation skews cell fate from apoptosis to senescence
Anerillas, C., Herman, A. B., Rossi, M., Munk, R., Lehrmann, E., Martindale, J. L., Cui, C.-Y., Abdelmohsen, K., De, S., & Gorospe, M. (2022) · Science Advances · doi:10.1126/sciadv.abm0756 · Cited by 71
The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets
Rossi, M., & Abdelmohsen, K. (2021) · Cells · doi:10.3390/cells10071740 · Cited by 71
Gong, P., Long, H., Guo, Y., Wang, Z., Yao, W., Wang, J., Yang, W., Li, N., Xie, J., & Chen, F. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116927 · Cited by 71
TP53 in Biology and Treatment of Osteosarcoma
Synoradzki, K. J., Bartnik, E., Czarnecka, A. M., Fiedorowicz, M., Firlej, W., Brodziak, A., Stasinska, A., Rutkowski, P. L., & Grieb, P. (2021) · Cancers · doi:10.3390/cancers13174284 · Cited by 70
Oxidative Stress-Induced Cellular Senescence in Aging Retina and Age-Related Macular Degeneration
Terao, R., Ahmed, T., Suzumura, A., & Terasaki, H. (2022) · Antioxidants · doi:10.3390/antiox11112189 · Cited by 69
“p21Cip1 binds to CDK2 and CDK4/6, causing cell cycle arrest at the G1 and S phases [71].”
BackgroundCellular Senescence in Liver Disease and Regeneration
Ferreira-Gonzalez, S., Rodrigo-Torres, D., Gadd, V. L., & Forbes, S. J. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1722262 · Cited by 59
Yang, Y., Jn-Simon, N., He, Y., Sun, C., Zhang, P., Hu, W., Tian, T., Zeng, H., Basha, S., Huerta, A. S., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00811-7 · Cited by 65
“Some studies show that HSC senescence may limit the extent of liver fibrosis 32 or contribute to liver fibrosis in a different model system 52 , whereas senescent cholangiocytes and LSECs may contribute to liver fibrosis by impairing liver regeneration and causing endothelial dysfunction,…”
Senescence in polyploid giant cancer cells: A road that leads to chemoresistance
Bharadwaj, D., & Mandal, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.11.002 · Cited by 64
Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
Zhou, S., Zhu, J., Zhou, P., & Gu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999600 · Cited by 61
“In the RIPF mouse model and senescent AT2 cells, the level of p21 increased significantly (Citrin et al., 2013; Yosef et al., 2017; Sainz de Aja et al., 2021).”
BackgroundKoyano, T., Namba, M., Kobayashi, T., Nakakuni, K., Nakano, D., Fukushima, M., Nishiyama, A., & Matsuyama, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-48557-8 · Cited by 61
Cellular senescence or stemness: hypoxia flips the coin
Otero-Albiol, D., & Carnero, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02035-0 · Cited by 58
Doolittle, M. L., Saul, D., Kaur, J., Rowsey, J. L., Vos, S. J., Pavelko, K. D., Farr, J. N., Monroe, D. G., & Khosla, S. (2023) · Nature Communications · doi:10.1038/s41467-023-40393-9 · Cited by 57
Doolittle, M. L., Saul, D., Kaur, J., Rowsey, J. L., Vos, S. J., Pavelko, K. D., Farr, J. N., Monroe, D. G., & Khosla, S. (2023) · doi:10.1101/2023.01.12.523760 · Cited by 57
Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer
Banerjee, P., Kotla, S., Velatooru, L. R., Abe, R. J., Olmsted‐Davis, E. A., Cooke, J. P., Schadler, K., Deswal, A. M., Herrmann, J., Lin, S. H., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.763930 · Cited by 57
Therapy-induced senescence as a component of tumor biology: Evidence from clinical cancer
Saleh, T., Bloukh, S., Hasan, M., & Shboul, S. A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188994 · Cited by 56
Identification of reference genes for RT-qPCR data normalisation in aging studies
González-Bermúdez, L., Anglada, T., Genescà, A., Martín, M., & Terradas, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-50035-0 · Cited by 58
Inflammaging, cellular senescence, and cognitive aging after traumatic brain injury
Lu, Y., Jarrahi, A., Moore, N. D., Bartoli, M., Brann, D. W., Baban, B., & Dhandapani, K. M. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106090 · Cited by 54
“…stress is associated with the induction of senescence pathways, including elevated expression of the cyclin-dependent kinase inhibitors, p16 INK4a and p21 WAF1/Cip1 (Rayess et al., 2012; Yosef et al., 2017), or the tumor suppressor gene, p53, which maintain cell cycle arrest (Rufini et al., 2013).”
Subcellular structure, heterogeneity, and plasticity of senescent cells
Bitencourt, T. C., Vargas, J. E., Silva, A. O., Fraga, L. R., & Filippi‐Chiela, E. (2024) · Aging Cell · doi:10.1111/acel.14154 · Cited by 46
“…stresses may act by similar SCAPs, the effector proteins responsible for cell survival may vary in response to different inducers (Yosef et al., 2016), depending on the genetic background and the intensity of cellular damage (Alsayegh et al., 2015 ; Baar et al., 2017; Yosef et al., 2017).”
BackgroundMiller, K. N., Li, B., Pierce-Hoffman, H. R., Patel, S., Lei, X., Rajesh, A., Teneche, M. G., Havas, A. P., Gandhi, A., Macip, C. C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57229-3 · Cited by 230
“CDKN1A (also known as p21) is thought to be required for ef fi cient DNA repair, including repair of DSBs 38 and has been shown to suppress DNA damage response (DDR)-associated toxicity in senescent cells 39 .”
p21cip1/waf1 Coordinates Autophagy, Proliferation and Apoptosis in Response to Metabolic Stress
Manu, K. A., Cao, P. H. A., Chai, T. F., Casey, P. J., & Wang, M. (2019) · Cancers · doi:10.3390/cancers11081112 · Cited by 54
“Interestingly, p21-induced senescence was recently suggested as pro–survival in nature, as its suppression results in the death of senescent cells [65].”
BackgroundBianchi, A., Mozzetta, C., Pegoli, G., Lucini, F., Valsoni, S., Rosti, V., Petrini, C., Cortesi, A., Gregoretti, F., Antonelli, L., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci128161 · Cited by 52
“p21 maintains the viability of DNA damage–induced senescent cells (46) and aberrant expression of p21 has been observed in EDMD-derived human myoblasts (47).”
BackgroundWalters, H., & Cox, L. S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6697861 · Cited by 52
Senescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection
Wandrer, F., Han, B., Liebig, S., Schlue, J., Manns, M. P., Schulze‐Osthoff, K., & Bantel, H. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14802 · Cited by 49
“In line with this finding is the recent observation of reduced liver fibrosis in p21-deficient mice.(35) Moreover, enhanced p21 expression of human hepatocytes has been associated with liver fibrosis.”
ResultMolecular mechanisms and cardiovascular implications of cancer therapy-induced senescence
Abdelgawad, I. Y., Sadak, K. T., Lone, D. W., Dabour, M. S., Niedernhofer, L. J., & Zordoky, B. N. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107751 · Cited by 50
Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells
Rysanek, D., Vašicová, P., Kolla, J. N., Sedlák, D., Anděra, L., Bártek, J., & Hodný, Z. (2022) · Aging · doi:10.18632/aging.204207 · Cited by 50
Fancy, N. N., Smith, A. M., Caramello, A., Tsartsalis, S., Davey, K., Muirhead, R. C. J., McGarry, A., Jenkyns, M. H., Schneegans, E., Chau, V., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02727-9 · Cited by 48
“We included an antibody for p21 CIP1 (p21, encoded by CDKN1A ), that functions to maintain the viability of DNA damage ‐ induced senescent cells and one for γ-H2AX, a marker of DNA double-strand breaks (DSBs) [2, 79].”
BackgroundHigh Phosphate Induces and Klotho Attenuates Kidney Epithelial Senescence and Fibrosis
Maique, J., Flores, B., Shi, M., Shepard, S., Zhou, Z., Yan, S., Moe, O. W., & Hu, M. C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01273 · Cited by 47
“Both p16 and p21 are well-known cell cycle regulators and involved in senescence activation (Satyanarayana and Rudolph, 2004; Yosef et al., 2017).”
BackgroundCrochemore, C., Molina, C. F., Montagne, B., Salles, A., & Ricchetti, M. (2019) · Nature Communications · doi:10.1038/s41467-019-13314-y · Cited by 47
Dobler, C., Jost, T., Hecht, M., Fietkau, R., & Distel, L. V. (2020) · Cells · doi:10.3390/cells9092012 · Cited by 47
Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases
Chen, Y., Yuan, S., Cao, Y., Kong, G., Jiang, F., Li, Y., Wang, Q., Tang, M., Zhang, Q., Wang, Q., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3206982 · Cited by 47
“Moreover, p21 can maintain the survival of senescent HSCs by inhibiting caspase and c-Jun N-terminal kinase (JNK) signals [38].”
BackgroundWong, G. C., & Chow, H. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220203 · Cited by 48
“Moreover, sustained activation of cell cycle inhibitors like p21 is also known to inhibit p53mediated apoptosis [62].”
BackgroundXing, L., Tang, X., Wu, K., Huang, X., Yi, Y., & Huan, J. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.10.012 · Cited by 46
“Indeed, p21, in further preventing the phosphorylation of pRb, is able to downregulate proliferation-related gene expression as well as facilitate cell senescence and apoptosis.(13,44) As a consequence of its systemic regulation by signaling factors, p21 can activate cell cycle checkpoints, while its cellular level is…”
BackgroundDistinct senotypes in p16- and p21-positive cells across human and mouse aging tissues
Saul, D., Jurk, D., Doolittle, M. L., Kosinsky, R. L., Han, Y., Zhang, X., Franco, A. C., Kim, S. Y., Wyles, S. P., Prakash, Y. S., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00601-2 · Cited by 45
“…elicit distinct secretory phenotypes, with the p21-driven phenotype promoting immunosurveillance (Sturmlechner et al, 2021). p21 upregulation has also been suggested as a mechanism that enables senescent cells to resist apoptosis, thereby facilitating their retention in tissues (Yosef et al, 2017).”
Feng, M., Kim, J., Field, K., Reid, C., Chatzistamou, I., & Shim, M. (2019) · FASEB BioAdvances · doi:10.1096/fba.2019-00041 · Cited by 42
Exercise-induced AMPK activation is involved in delay of skeletal muscle senescence
Yoon, K. J., Zhang, D., Kim, S.-J., Lee, M.-C., & Moon, H. Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.086 · Cited by 44
Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer
Pardella, E., Pranzini, E., Nesi, I., Parri, M., Spatafora, P., Torre, E., Muccilli, A., Castiglione, F., Fambrini, M., Sorbi, F., et al. (2022) · Cells · doi:10.3390/cells11244026 · Cited by 43
Lossaint, G., Horvat, A., Gire, V., Bačević, K., Mrouj, K., Charrier‐Savournin, F., Georget, V., Fisher, D., & Dulić, V. (2022) · Journal of Cell Science · doi:10.1242/jcs.259114 · Cited by 43
Fang, J., & Liang, W. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.07.059 · Cited by 42
Autophagy and senescence in cancer therapy
Patel, N. H., Bloukh, S., Alwohosh, E., Alhesa, A., Saleh, T., & Gewirtz, D. A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.002 · Cited by 42
Liu, Z., Wang, K., Jiang, C., Chen, Y., Liu, F., Xie, M., Yim, W. Y., Yao, D., Qian, X., Chen, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202307319 · Cited by 41
Cellular Senescence in Traumatic Brain Injury: Evidence and Perspectives
Schwab, N., Leung, E., & Hazrati, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.742632 · Cited by 40
Oridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells.
Yasuda, S., Horinaka, M., Iizumi, Y., Goi, W., Sukeno, M., & Sakai, T. (2021) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2021.12.098 · Cited by 34
Vodicka, P., Andera, L., Opattova, A., & Vodickova, L. (2021) · Cancers · doi:10.3390/cancers13030479 · Cited by 39
Role of melanoma inhibitory activity in melanocyte senescence
Feuerer, L., Lamm, S., Henz, I., Kappelmann‐Fenzl, M., Haferkamp, S., Meierjohann, S., Hellerbrand, C., Kuphal, S., & Bosserhoff, A. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12801 · Cited by 39
“There is not much known about the role of p21 in the perpetuation of senes‐ cence, but the bypass of senescence after p21 knockout in fibro‐ blasts has been previously described (Brown, Wei, & Sedivy, 1997; Romanov et al., 2010; Stein, Drullinger, Soulard, & Dulic, 1999; Yosef et al., 2017).”
BackgroundBarbosa, D. M., Fahlbusch, P., de Wiza, D. H., Jacob, S., Kettel, U., Al‐Hasani, H., Krüger, M., Ouwens, D. M., Hartwig, S., Lehr, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61886-3 · Cited by 39
Mechanotransduction for therapeutic approaches: Cellular aging and rejuvenation
Han, H.-M., Kim, S.-Y., & Kim, D. (2025) · APL Bioengineering · doi:10.1063/5.0263236 · Cited by 39
“108 The SASP secretome is another hallmark of senescence.”
Zhang, H., Gui, T., Liu, R., Tong, K., Wu, C., Li, Z., Huang, X., Xu, Q., Yang, J., Tang, W., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03416-1 · Cited by 38
Senescence in cancer: Advances in detection and treatment modalities
Billimoria, R., & Bhatt, P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115739 · Cited by 38
Caland, L., Labbé, P., Mamarbachi, M., Villeneuve, L. R., Ferbeyre, G., Noly, P., Carrier, M., Thorin‐Trescases, N., & Thorin, É. (2019) · Aging · doi:10.18632/aging.102020 · Cited by 37
“Recently, we reported a strong relationship between arterial expression of p21 , a cell cycle inhibitor overexpressed in senescent cells and maintaining growth arrest [35], and circulating levels of angptl2 in atherosclerotic patients [36].”
BackgroundEffects and potential mechanisms of IGF1/IGF1R in the liver fibrosis: A review
Gui, R., Li, W., Li, Z., Wang, H., Wu, Y., Jiao, W., Zhao, G., Shen, Y., Wang, L., Zhang, J., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126263 · Cited by 35
Zhao, S., Wang, X., Zheng, X., Xiu, L., Wang, Z., Zhang, J., Zhao, X., Zhuang, S., Pan, Q., Sun, F., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.025 · Cited by 36
Piperine: An Anticancer and Senostatic Drug
Lim, J. S., Lee, D. Y., Lim, J. H., Oh, W. K., Park, J. T., Park, S. C., & Cho, K. A. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2704137 · Cited by 35
“3 Piperine Induces Extracellular Signal-Regulated Kinase (Erk1/2) and c-Jun N-Terminal Kinase (JNK) Phosphorylation in Senescent Cells Mitogen-activated protein kinases (MAPKs), including Erk1/2, p38, and JNK, have been implicated in senescence phenotypes such as growth arrest [30,31], apoptosis resistance [32], and t…”
BackgroundExploring cellular senescence in the musculoskeletal system: Any insights for biomarkers discovery?
Gerosa, L., Malvandi, A. M., Malavolta, M., Provinciali, M., & Lombardi, G. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101943 · Cited by 35
“damage-dependent activation of JNK and caspase signaling (Yosef et al., 2017).”
BackgroundWang, Y., Wang, Y., Yang, M., & Ma, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111191 · Cited by 34
The protective role of omentin-1 in IL-1β-induced chondrocyte senescence
Chai, B., Zheng, Z., Liao, X., Li, K.-Y., Liang, J.-S., Huang, Y., Tong, C.-J., Ou, D.-J., & Lu, J. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1699803 · Cited by 34
“Both p21 and PAI-1 are recognised as important senescence mediators and signature factors [18,19].”
BackgroundHansel, C., Barr, S., Schemann, A. V., Lauber, K., Hess, J., Unger, K., Zitzelsberger, H., Jendrossek, V., & Klein, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137064 · Cited by 33
“Upon increased cellular stress, including RT-induced cellular oxidative stress, and subsequent DNA damage repair induction, activated p53 can impact on p21, which bears the capacity to promote senescence through apoptosis inhibition [49,50].”
Backgroundp21 regulates expression of ECM components and promotes pulmonary fibrosis via CDK4 and Rb
Papismadov, N., Levi, N., Roitman, L., Agrawal, A., Ovadya, Y., Cherqui, U., Yosef, R., Akiva, H., Gal, H., & Krizhanovsky, V. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00246-7 · Cited by 34
“By 7 days post-treatment, the cells had acquired the senescence phenotype (Yosef et al, 2017).”
InfluentialSelf-citationOdeh, A., Dronina, M. A., Domankevich, V., Shams, I., & Manov, I. (2019) · Aging Cell · doi:10.1111/acel.13045 · Cited by 32
“A similar treatment regimen with low etoposide concentrations was used in previous reports to induce senescence and SASP in dif‐ ferent normal and cancer cells (Gu & Kitamura, 2012; Leontieva & Blagosklonny, 2010; Yosef et al., 2017).”
MethodHuff, W. X., Bam, M., Shireman, J. M., Kwon, J. H., Song, L., Newman, S., Cohen‐Gadol, A., Shapiro, S., Jones, T., Fulton, K., et al. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2100008 · Cited by 33
Metadata
- Authors
- Yosef, R., Pilpel, N., Papismadov, N., Gal, H., Ovadya, Y., Vadai, E., Miller, S., Porat, Z., Ben‐Dor, S., & Krizhanovsky, V.
- Affiliations
- Weizmann Institute of Science (IL)
- Corresponding author
- Krizhanovsky, Valery
- Venue
- The EMBO Journal
- Published
- 2017-06-12
- Volume
- 36
- Issue
- 15
- Pages
- 2280-2295
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC5538795
- OpenAlex
- W2624008928
- Cited by
- 293
- References
- 58
- Citations by year
- 2026: 24 · 2025: 38 · 2024: 39 · 2023: 41 · 2022: 36 · 2021: 50 · 2020: 27 · 2019: 26 · 2018: 11 · 2017: 1
- FWCI
- 13.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Research Council (309688)
- Israel Science Foundation (634/15)
- Bruce Kanter Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, p21, DNA damage response, ATM, NF-κB signaling, JNK signaling, caspase signaling, TNF-α, liver stellate cells, liver fibrosis, collagen synthesis, aging
- MeSH terms
- Animals, Cell Line, Cell Survival, DNA Damage, Gene Expression Regulation, Humans, Caspases, MAP Kinase Signaling System, Cyclin-Dependent Kinase Inhibitor p21, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.